Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07310407
PHASE2

Rutin and Vitamin C in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

Sponsor: Ain Shams University

View on ClinicalTrials.gov

Summary

evaluate the combined effects of Rutin and Vitamin C versus Vitamin C alone on selected oxidative stress markers, inflammation, hepatic steatosis regression, and associated metabolic parameters in patients with MASLD

Official title: Evaluation of the Effect of Rutin and Vitamin C in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

120

Start Date

2026-01-01

Completion Date

2027-03-01

Last Updated

2025-12-30

Healthy Volunteers

No

Conditions

Interventions

DRUG

Rutin + Vitamin C

Type: Drug (Combination therapy) Details: Oral administration of two tablets containing 60 mg Rutin + 160 mg Vitamin C, taken three times daily for 12 weeks.

DRUG

Vitamin C 500mg

Type: Drug (Single agent) Oral administration of Vitamin C 500 mg, taken twice daily for 12 weeks

BEHAVIORAL

Lifestyle Intervention

Mediterranean diet focusing on fruits, vegetables, whole grains, healthy fats, plus structured exercise program for 12 weeks.

Locations (1)

National Hepatology and Tropical Medicine Research Institute (NHTMRI)

Cairo, Egypt